Bath Savings Trust Co cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 8.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 43,571 shares of the pharmacy operator’s stock after selling 4,190 shares during the period. Bath Savings Trust Co’s holdings in Walgreens Boots Alliance were worth $2,615,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Roof Eidam & Maycock ADV bought a new position in shares of Walgreens Boots Alliance in the 1st quarter worth $1,877,000. Endurant Capital Management LP raised its position in shares of Walgreens Boots Alliance by 422.9% in the 4th quarter. Endurant Capital Management LP now owns 180,223 shares of the pharmacy operator’s stock worth $13,088,000 after acquiring an additional 145,759 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its position in shares of Walgreens Boots Alliance by 17.2% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 116,893 shares of the pharmacy operator’s stock worth $8,489,000 after acquiring an additional 17,145 shares in the last quarter. Mariner LLC raised its position in shares of Walgreens Boots Alliance by 92.0% in the 1st quarter. Mariner LLC now owns 120,317 shares of the pharmacy operator’s stock worth $7,877,000 after acquiring an additional 57,645 shares in the last quarter. Finally, Altman Advisors Inc. bought a new position in shares of Walgreens Boots Alliance in the 4th quarter worth $1,570,000. 60.27% of the stock is owned by institutional investors and hedge funds.
Walgreens Boots Alliance traded up $1.62, hitting $62.38, on Thursday, Marketbeat Ratings reports. 12,388,947 shares of the company’s stock were exchanged, compared to its average volume of 6,221,250. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $83.89. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47. The company has a market cap of $60.30 billion, a price-to-earnings ratio of 12.19, a price-to-earnings-growth ratio of 1.00 and a beta of 1.12.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.47 by $0.06. The business had revenue of $34.33 billion for the quarter, compared to the consensus estimate of $34.15 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The company’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.33 EPS. equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.97 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 12th. Shareholders of record on Monday, August 20th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 2.82%. The ex-dividend date of this dividend is Friday, August 17th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. Walgreens Boots Alliance’s payout ratio is presently 31.37%.
WBA has been the subject of several recent research reports. Barclays initiated coverage on Walgreens Boots Alliance in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price target for the company. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Thursday, March 22nd. TheStreet lowered Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research report on Tuesday, March 20th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $74.00 target price on the stock in a research note on Thursday, March 22nd. Finally, Pivotal Research dropped their target price on Walgreens Boots Alliance from $73.00 to $69.00 and set a “hold” rating on the stock in a research note on Friday, March 23rd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Hold” and a consensus price target of $78.47.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total transaction of $179,372.16. Following the sale, the director now owns 13,679 shares in the company, valued at approximately $896,795.24. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.80% of the stock is currently owned by insiders.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.